The Leadership Team at Design Therapeutics drives the strategic vision and operational excellence of the company, guiding the development of innovative GeneTACs™ to effectively target and modify the underlying causes of inherited nucleotide repeat expansion diseases. With a blend of entrepreneurial spirit and operational expertise, this team fosters collaboration, aligns resources, and ensures the successful advancement of therapeutic candidates through clinical development.
View all